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Abstract
Background: Ascertaining stroke severity in claims data-based studies is difficult because clinical information is
unavailable. We assessed the predictive validity of a claims-based stroke severity index (SSI) and determined
whether it improves case-mix adjustment.
Methods: We analyzed patients with acute ischemic stroke (AIS) from hospital-based stroke registries linked with a
nationwide claims database. We estimated the SSI according to patient claims data. Actual stroke severity measured
with the National Institutes of Health Stroke Scale (NIHSS) and functional outcomes measured with the modified
Rankin Scale (mRS) were retrieved from stroke registries. Predictive validity was tested by correlating SSI with mRS.
Logistic regression models were used to predict mortality.
Results: The SSI correlated with mRS at 3 months (Spearman rho = 0.578; 95 % confidence interval [CI], 0.556–0.600),
6 months (rho = 0.551; 95 % CI, 0.528–0.574), and 1 year (rho = 0.532; 95 % CI 0.504–0.560). Mortality models with the
SSI demonstrated superior discrimination to those without. The AUCs of models including the SSI and models with the
NIHSS did not differ significantly.
Conclusions: The SSI correlated with functional outcomes after AIS and improved the case-mix adjustment of mortality
models. It can act as a valid proxy for stroke severity in claims data-based studies.
Keywords: Acute ischemic stroke, Claims data, Disease severity, National Health Insurance Research Database,
Outcomes research
Background
With the advent of information technology, large amounts
of health care utilization data are collected routinely for
reimbursement purposes and the administration of health
services. These administrative claims data offer several
potential advantages to researchers, including large
sample sizes, representativeness, being of large quantity
and serial longitudinal, comparatively low cost, and
relative efficiency [1]. Therefore, in addition to clinical
epidemiological research [2], administrative claims data
are appropriate for examining outcomes, performing
pharmaco-economic analysis, and monitoring the quality
of clinical care [3, 4].
However, because of insufficient clinical information,
studies using administrative claims data have shared a
crucial shortcoming, namely, a lack of adjustment for
disease severity. This limitation is particularly relevant
for stroke outcomes research because the heterogeneity
of stroke syndromes causes stroke severity to vary greatly
among patients. For example, studies based on adminis-
trative claims data that have investigated mortality and
readmission rates in stroke patients have generally been
limited by inadequate adjustment for stroke severity [5, 6].
In addition, claims data-based risk models for predicting
mortality and readmission might be prone to mischarac-
terizing the quality of stroke care delivered by hospitals,
because stroke severity is not included in the models [7].
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Therefore, it has been advocated that more research be
done to ascertain stroke severity using administrative billing
codes or electronic health records [8].
Administrative claims data reflect routine clinical prac-
tice and could be analyzed as a set of proxies that in-
directly represent the health status of patients [9]. In
response to the pressing need for a better ascertain-
ment of stroke severity using administrative claims
data, we previously developed several models to derive
a stroke severity index (SSI) that reflects the stroke
severity of patients hospitalized for acute ischemic stroke
(AIS), using only the information generally available in
claims data [10]. Before the SSI can be applied to measure
stroke severity in claims-based research, its criterion-
related validity should be examined. Criterion-related
validity is the extent to which the score from a new
measurement instrument correlates with that of other
measures evaluating the same or a very similar con-
struct [11]. We have assessed the concurrent validity, a
type of criterion-related validity, of the SSI by demon-
strating its close correlation with the actual severity of
neurological deficit at admission as assessed using the
National Institutes of Health Stroke Scale (NIHSS) [10],
the current gold standard to measure stroke severity.
In the current study, we aimed to evaluate the predictive
validity, another type of criterion-related validity, of the
SSI by examining the extent to which the SSI predicts
future functional outcomes with a cohort of stroke pa-
tients by cross-linking hospital-based registry databases
with a nationwide claims database. We also investigated
whether the SSI has improved the case-mix adjustment in
claims data-based outcomes research by examining the
magnitude of improvement in model performance when
the SSI was added to models that attempted to predict
mortality in patients with AIS.
Methods
Study population
We identified adult patients with AIS in stroke registries
from the 1300-bed Chi Mei Medical Center and the
regional 600-bed Landseed Hospital in Taiwan. Patients
admitted to the two hospitals between August 2006 and
December 2010 due to AIS were included. Patients with
in-hospital stroke were excluded. The study hospitals
prospectively registered all stroke patients admitted
within 10 days of symptom onset conforming to the
design of the nationwide Taiwan Stroke Registry [12].
Ischemic stroke was defined as an acute onset of neuro-
logic deficits persisting longer than 24 h with no
hemorrhage visible in the first brain computed tomog-
raphy or with acute corresponding ischemic lesion(s) on
diffusion weighted magnetic resonance imaging. Stroke
severity was determined using the NIHSS at admission.
The NIHSS is a 15-item neurologic examination scale
designed to assess neurological deficits in stroke patients.
The total NIHSS scores range from 0 to 42, with higher
values representing greater stroke severity.
The functional status of patients who consented to
follow-up was evaluated with the modified Rankin Scale
(mRS) at 3 months, 6 months, and 1 year after stroke,
during an in-person assessment or by telephone inter-
view. The mRS is a commonly used tool for measuring
the degree of disability of stroke patients. It is a six-
point scale with 0 for no symptoms, higher scores for
increasing disability, and 6 for death. Although a struc-
tured interview format has been developed to improve
the assessment of the mRS [13], the mRS was deter-
mined based on the Chinese translation of the mRS cri-
teria according to the Taiwan Stroke Registry operation
manual [12]. We dichotomized mRS at ≤ 2 versus > 2 in
accordance with previous stroke trials [14]. An mRS
score of ≤ 2 indicates a good functional outcome (slight
or no disability with preserved ability to look after own
affairs without assistance). An mRS score of >2 means a
poor functional outcome (dependence in daily activities
or death). To assure patient anonymity, the data col-
lected were limited to gender, birth date, admission date,
discharge date, admission NIHSS score, and follow-up
mRS scores from the registry databases (Fig. 1). Both the
Chi Mei Medical Center Institutional Review Board and
the Landseed Hospital Institutional Review Board ap-
proved the study protocol. Because the present study
involved analysis of secondary data and all patient data
Fig. 1 Flow diagram of study procedure. Abbreviations: CMMC, Chi
Mei Medical Center; ICD-9-CM, International Classification of Diseases,
Ninth Revision, Clinical Modification; LH, Landseed Hospital; mRS,
modified Rankin scale; NHIRD, National Health Insurance Research
Database; NIHSS, National Institutes of Health Stroke Scale
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were deidentified, a signed informed consent to partici-
pate in the study was determined unnecessary.
National Health Insurance Research Database linkage
The National Health Insurance (NHI) is a mandatory,
single-payer enrollment healthcare program that covers
nearly the entire population of Taiwan. The program
provides universal coverage for prescription medications,
inpatient care, and ambulatory care. The National Health
Insurance Research Database (NHIRD) comprises medical
care claims data on NHI enrollees and is maintained and
released for research by the National Health Research
Institutes of Taiwan.
To identify the inpatient population of patients with
AIS in the NHIRD, we extracted data on all patients
hospitalized between August 2006 and December 2010
for ischemic stroke (International Classification of Diseases,
Ninth Revision, Clinical Modification [ICD-9-CM] diagno-
sis code 433.x or 434.x) as their primary discharge diagnosis
[15] from an NHIRD data set. We then linked registry
data with the NHIRD according to 4 nonunique patient
characteristics: gender, date of birth, admission date, and
discharge date (Fig. 1) [15]. Because errors in coding or
entering data in administrative claims data might be
present, failure of linkage is inevitable [16]. Patients
who were successfully linked and had follow-up mRS
scores comprised the validation cohort. The linked
hospitalization record in the NHIRD was defined as the
index hospitalization.
For each case in the validation cohort, we obtained all
the diagnosis codes from the index hospitalization as
well as inpatient and outpatient claims within the 1-year
look-back period before the index hospitalization using
all the available nationwide claims records (Fig. 1).
Patients were identified as having a comorbid condition
if its corresponding ICD-9-CM codes appeared in at
least one inpatient claim or three outpatient claims
during the 1-year look-back period [17]. We estimated
the modified Charlson comorbidity index (CCI) according
to the ICD-9-CM diagnosis codes [18]. In addition, we
retrieved reimbursement data for medications, laboratory
tests, imaging studies, procedures, and clinical services
from the index hospitalization, which were used to esti-
mate the SSI for each patient.
Stroke severity index
We have previously developed several SSI models using
various regression methods, including k-nearest neighbor
regression, regression tree, and multiple linear regression,
based on the data from 3577 patients with AIS in a single
hospital [10]. This index predicts the neurological deficit
severity of patients hospitalized for AIS according to seven
predictors (Table 1). These predictors essentially reflect
the care given to stroke patients and management of
stroke-related complications, which generally correlate
with stroke severity [19, 20]. For example, among stroke
patients, frequent airway suctioning is generally needed
for those with difficulty in handling their own secretions,
the placement of a nasogastric tube for feeding is usually
required for those with dysphagia, bacterial sensitivity
tests are often performed for those with severe stroke and
therefore prone to infections, and mannitol osmotherapy
is frequently prescribed for those with brain edema
[19, 20].
An online tool (http://hdmlab.twbbs.org:508/SSI/hdmlab/
ssi2.jsp) accompanying our previous study is available for
estimation of the SSI using three kinds of regression
methods. In the present study, we used the multiple linear
regression model because it is simple to implement and to
disseminate to other researchers. We determined the
presence of each predictor according to the administra-
tive billing codes (see Additional file 1: Table S1) listed
in each patient’s claims from the index hospitalization.
If a patient was transferred to another hospital during
the index hospitalization, the claims records from the
second hospitalization were ignored. The SSI was ob-
tained by using the regression coefficients estimated
from a multiple linear regression equation in our previous
study (Table 1) [10].
Statistical analysis
Continuous variables were summarized with mean
(standard deviation) or median (interquartile range), and
categorical variables with frequency and percentages.
Two-tailed P values of < 0.05 were considered significant.
To summarize the relationships between stroke severity
and outcomes after stroke, the NIHSS was categorized
as mild (≤5), moderate (> 5 to ≤ 13), or severe (> 13)
stroke in accordance with a prior study [21], in which
the NIHSS was used to predict stroke outcome. Because
the SSI can be converted to the NIHSS as follows:
NIHSS = 1.1722 × SSI − 0.7533 (see Additional file 1:
Table S2), we categorized patients as having mild (SSI ≤ 5),
moderate (SSI > 5 to ≤ 12), or severe (SSI > 12) stroke in




Bacterial sensitivity test 1.3642
General ward stay -5.5761
ICU stay 4.1770
Nasogastric intubation 4.5809
Osmotherapy (mannitol or glycerol) 2.1448
Urinary catheterization 1.6569
Constant 9.6804
ICU intensive care unit
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accordance with the study mentioned above. Chi-squared
tests for trend were used to evaluate trends across the
categories of stroke severity.
To assess the predictive validity of the SSI (the extent
to which the SSI predicts future functional outcomes),
we examined the Spearman rank correlations between
the SSI and the mRS at 3 months, 6 months, and 1 year.
The correlations between the NIHSS and the mRS were
also estimated. We further tested whether the correla-
tions between the SSI and the mRS and those between
the NIHSS and the mRS were equal [22].
To investigate the performance of models in predicting
mortality at 3 months, 6 months, and 1 year after stroke,
we fitted separate logistic regression models using age,
sex, vascular risk factors (hypertension, diabetes mellitus,
hyperlipidemia, prior stroke, atrial fibrillation, coronary
heart disease, chronic kidney disease), and modified CCI
as covariates with or without the SSI. The modified CCI
was dichotomized into low comorbidity (0 or 1) and
high comorbidity (≥ 2) for analysis [18]. The SSI was
entered as a continuous variable. For comparison, addi-
tional logistic regression procedures were performed using
age, sex, vascular risk factors, modified CCI, and the
NIHSS as covariates. The NIHSS was also treated as a
continuous variable. Model discrimination was assessed
and compared using the area under the receiver operating
characteristic curve (AUC) as recommended by DeLong
[23]. We used integrated discrimination improvement
(IDI) to evaluate the improvement of predictive ability
after adding either the SSI or the NIHSS to the models
[24]. A higher IDI indicates greater risk discrimination
and improved classification. We assessed the model cali-
bration by the Hosmer–Lemeshow goodness-of-fit test.
All the statistical analyses were performed using Stata 13.1
(StataCorp, College Station, Texas).
Results
In total, 4438 (Chi Mei Medical Center) and 1148
(Landseed Hospital) adult patients hospitalized for AIS
were identified from the stroke registries of the two
study hospitals. After linkage with the NHIRD, 3816 and
962 patients, respectively, were successfully linked (Fig. 1).
Overall, the rate of successful linkage was 85.5 %. Com-
pared with the unlinked patients, the NHIRD-linked pa-
tients were slightly younger and had somewhat lower
NIHSS (see Additional file 1: Table S3). Among the 4778
linked patients, follow-up mRS scores were available for
3630 patients at 3 months after stroke, 3545 at 6 months,
and 2478 at 1 year. Patients with follow-up mRS were
marginally older and had slightly lower NIHSS than those
without (see Additional file 1: Table S4). Table 2 lists
the characteristics of the validation cohort. The mor-
tality rates were 4.7 % at 3 months, 7.0 % at 6 months,
and 14.2 % at 1 year, which were comparable with
those (30-day mortality 4.2 to 4.3 %; 1-year mortality
13.9 %) found in previous nationwide studies [25, 26].
Of the 3630 patients in the validation cohort, 2188
(60.3 %) were categorized as having mild stroke
(NIHSS ≤ 5), 863 (23.8 %) as having moderate stroke
(NIHSS > 5 to ≤ 13), and 579 (16.0 %) as having severe
stroke (NIHSS > 13). According to the SSI, 2404 (66.2 %)
were categorized as having mild stroke (SSI ≤ 5), 630
(17.4 %) as having moderate stroke (SSI > 5 to ≤ 12), and
596 (16.4 %) as having severe stroke (SSI > 12). Figure 2
illustrates the proportions of mortality and good func-
tional outcome (mRS ≤ 2) across the NIHSS and SSI
categories at 3 months, 6 months, and 1 year after
stroke. With rising stroke severity, as assessed using
either the NIHSS or the SSI, the risk of mortality in-
creased and the probability of good functional outcome
decreased significantly (all were P < 0.001, chi-squared
tests for trend).
Table 2 Characteristics of the validation cohort
Characteristics n = 3630
Age, mean (SD) 67.6 (12.7)
Female 1474 (40.6)
LOS, median (IQR) 5 (4–9)
Modified CCI
0 or 1 2512 (69.2)
≥ 2 1118 (30.8)
Vascular risk factors
Hypertension 2729 (75.2)
Diabetes mellitus 1658 (45.7)
Hyperlipidemia 1445 (39.8)
Prior stroke 689 (19.0)
Atrial fibrillation 360 (9.9)
Coronary heart disease 198 (5.5)
Chronic kidney disease 103 (2.8)
Stroke severity
NIHSS, mean (SD) 7.1 (7.8)
SSI, mean (SD) 6.8 (4.8)
Components of SSI
Airway suctioning 542 (14.9)
Bacterial sensitivity test 553 (15.2)
General ward stay 3602 (99.2)
ICU stay 387 (10.7)
Nasogastric intubation 802 (22.1)
Osmotherapy (mannitol or glycerol) 192 (5.3)
Urinary catheterization 742 (20.4)
Data are numbers (percentage) unless specified otherwise
CCI Charlson comorbidity index, ICU intensive care unit, IQR interquartile
range, LOS length of stay, NIHSS National Institutes of Health Stroke Scale,
SD standard deviation, SSI stroke severity index
Sung et al. BMC Health Services Research  (2016) 16:509 Page 4 of 9
The SSI correlated significantly with the 3-month mRS
(Spearman rho = 0.578; 95 % confidence interval [CI],
0.556–0.600), 6-month mRS (rho = 0.551; 95 % CI,
0.528–0.574), and 1-year mRS (rho = 0.532; 95 % CI
0.504–0.560), indicating a decrease in the magnitude of
correlation over time. The admission NIHSS also corre-
lated significantly with the 3-month mRS (rho = 0.674;
95 % CI, 0.656–0.692), 6-month mRS (rho = 0.640; 95 %
CI, 0.620–0.659), and 1-year mRS (rho = 0.595; 95 % CI
0.569–0.620). The correlations between the SSI and the
mRS were lower than those between the NIHSS and the
mRS (P < 0.001 for 3-month mRS, P < 0.001 for 6-month
mRS, and P = 0.001 for 1-year mRS). Figure 3 illustrates
the distribution of the SSI and the NIHSS across all
mRS grades at 3 months, 6 months, and 1 year after
stroke. The SSI showed a floor effect with mRS ≤ 2.
Table 3 reports the performance of the logistic regres-
sion models for 3-month, 6-month, and 1-year mortality.
Based on the Hosmer-Lemeshow statistics, all models
demonstrated adequate model fit. For the base models
including age, sex, vascular risk factors, and the modified
CCI as covariates, the AUCs for 3-month, 6-month, and
1-year mortality models were 0.786, 0.777, and 0.767,
respectively. Including the SSI in the models improved
model discrimination substantially (AUCs for 3-month,
6-month, and 1-year mortality models, 0.869, 0.844, and
0.823, respectively; all were P < 0.001 as compared with
the base models). Similarly, model discrimination was
enhanced by adding the NIHSS to the base models
(AUCs for 3-month, 6-month, and 1-year mortality
models, 0.860, 0.837, and 0.816, respectively; all were
P < 0.001 as compared with the base models). The
AUCs of the models including the SSI and models with
the NIHSS did not differ significantly (P = 0.347 for 3-
month mortality, P = 0.409 for 6-month mortality, and
P = 0.353 for 1-year mortality). The IDI also indicated
that adding stroke severity, as assessed using either the
SSI or the NIHSS, to mortality models significantly im-
proved model discrimination.
Discussion
Our study demonstrated that the claims-based SSI could
be a feasible proxy indicator for stroke severity when
conducting outcomes research using claims data. The
predictive validity of the SSI was shown by its significant
correlations with the follow-up mRS up to 1 year. The SSI
helped predict long-term stroke outcomes, including mor-
tality and functional outcomes, just as the NIHSS did.
Fig. 2 Mortality and proportions of good functional outcomes stratified by stroke severity at 3 months (a, b), 6 months (c, d), and 1 year (e, f)
after stroke. Abbreviations: mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SSI, stroke severity index
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Adding the SSI to mortality risk models based on claims
data for patients with AIS considerably improved model
discrimination and the magnitude of improvement was
similar to that when the NIHSS was added to the models.
Stroke severity, as assessed using the NIHSS or other
stroke scales, is not only a strong predictor of stroke
outcomes such as mortality and readmission [27, 28],
but also a major determinant of hospital costs for stroke
patients [29]. Without information about stroke severity,
the results of stroke outcomes research could be biased.
A study found that including the NIHSS by linkage with
the Get With The Guidelines–stroke registry to a claims-
based 30-day mortality model, which was used for profiling
hospital performance in AIS treatment, both enhanced
model discrimination and improved hospital performance
rankings substantially [30]. Nevertheless, the opportunity
to link claims data with a nationwide clinical registry is
generally unavailable to researchers, and record linkage
may be restricted by privacy concerns and regulatory con-
straints [31]. In circumstances where information on
clinical stroke severity is unavailable, the claims-based
SSI could be used for risk adjustment in outcomes re-
search using solely claims data.
Various proxy measures of stroke severity have been
used in previous claims data-based studies, including
length of stay [32], total medical expenditure during
stroke hospitalization [33], stroke-related neurological
deficits (e.g., hemiplegia and aphasia) and complications
(e.g., pneumonia and decubitus ulcers) [33–35], and pro-
cedures (e.g., mechanical ventilation and craniotomy)
[34, 35]. However, our previous work found that many
of these measures might not be valid indicators of stroke
severity [25]. On the contrary, the SSI has been externally
validated by its strong correlation with clinical stroke
severity as measured using the NIHSS [10].
Some may argue that the SSI measure depends on
management and treatment given to stroke patients during
hospitalization and its performance might thus be affected
by variations in practice among physicians and differences
in resources across hospitals. Furthermore, physicians
may selectively withhold certain management or treat-
ment from some patients, in particular those with very
severe stroke because they are expected to die anyway.
Despite these concerns, the components of the SSI are
widely available in hospitals throughout Taiwan, leading
to its consistent performance across cohorts from 4
hospitals of different sizes and types [10]. Because the
SSI is superior to other proxy measures of stroke severity
[25], for the time being it is a reasonable substitute for a
clinical stroke scale in doing research with administrative
claims data, in which clinical information is unavailable.
In addition to stroke outcomes research [5, 6, 32, 36],
administrative claims data have been widely used in other
types of stroke studies, including health care utilization
[35, 37, 38], and studies investigating risk factors for
stroke [39–41]. However, only a few studies have
attempted to use information available in claims data
as surrogates for stroke severity [32, 34–37]. With the
capability to estimate stroke severity based on claims
data, the SSI could be applied in these claims data-
based stroke studies. For studies that investigate risk
factors for stroke, we could compare the stroke severity
between patients with or without the presumed risk factor
Fig. 3 Box-plots showing the distribution of the SSI and the NIHSS
across all mRS grades at 3 month (a), 6 months (b), and 1 year (c)
after stroke. Abbreviations: mRS, modified Rankin Scale; NIHSS,
National Institutes of Health Stroke Scale; SSI, stroke severity index
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and, thus, might refine the inferences of such associations.
Furthermore, with its ability to predict long-term stroke
outcomes, the SSI could assist surveillance of stroke bur-
den using administrative claims data. For example, investi-
gators could examine the temporal trends and spatial
variations in patient stroke severity in addition to stroke
incidence. The results of such studies may promote
effective planning for health care facilities.
Our study has limitations. First, the study patients
were enrolled from only 2 hospitals, one being a medical
center and the other a regional hospital, and might not
be representative of the general population. In Taiwan,
approximately 70 % of stroke patients are admitted to
medical centers and regional hospitals, with the remain-
der admitted to district hospitals [35]. However, the
seven SSI components are quite ordinary and widely
available at each level of hospital providing acute care
for patients with stroke. Thus the SSI would not be
affected significantly by the size or type of a hospital.
Second, distribution of stroke severity is typically skewed
toward mild symptoms [42]. As shown in our study,
more than half of the patients had mild stroke. However,
unlike the NIHSS, the lowest possible value of the SSI
was not zero according to the regression equation
(Table 1). Consequently, the SSI has a floor effect and is
insensitive when discriminating patients with mild
stroke. Third, the study results may not be generalized
to administrative claims databases other than Taiwan’s
NHIRD. Given the kind of administrative information,
i.e., administrative billing codes, required, which are
typically collected in healthcare systems operating on a
fee-for-service basis, the SSI may not be applicable in
organizational context that do not have such accounting
schemes. More validation studies are required to test the
generalizability of this index to other administrative
databases and in other healthcare systems. Fourth, the
SSI is probably not suitable for case mix adjustment
when comparing hospital performance in the future
because this method might create an incentive to over-
report management and treatment to hospitals that
attempt to promote their ranking among hospitals.
However, the SSI has its merit in conducting stroke out-
come studies with the existing NHIRD datasets [26].
Conclusions
The claims-based SSI is a valid substitute for the NIHSS
for estimating the stroke severity of patients hospitalized
for AIS. The SSI correlated with functional outcomes up
to 1 year after stroke and it improved case-mix adjust-
ment for mortality to a similar degree as that of the
NIHSS. The SSI has the potential to improve stroke
research based on administrative claims data.
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Additional file 1: Table S1. Predictors of the stroke severity index and
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fee schedule. Table S2. Distribution of the NIHSS score across stroke
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characteristic curve; CCI: Charlson comorbidity index; CI: Confidence interval;
ICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical
Modification; IDI: Integrated discrimination improvement; mRS: Modified
Rankin Scale; NHI: National Health Insurance; NHIRD: National Health
Insurance Research Database; NIHSS: National Institutes of Health Stroke
Scale; SSI: Stroke severity index
Table 3 Performance of mortality models for acute ischemic stroke
AUC (95 % CI) Hosmer-Lemeshow statistic P IDI (95 % CI) P
Mortality at 3 months
Base model 0.786 (0.752–0.819) 6.39 0.604 Reference
Model with SSI 0.869 (0.844–0.894) 7.07 0.529 0.102 (0.079–0.124) <0.001
Model with NIHSS 0.860 (0.833–0.887) 7.17 0.519 0.085 (0.064–0.106) <0.001
Mortality at 6 months
Base model 0.777 (0.748–0.805) 5.13 0.744 Reference
Model with SSI 0.844 (0.819–0.869) 5.41 0.713 0.097 (0.077–0.116) <0.001
Model with NIHSS 0.837 (0.812–0.862) 5.86 0.662 0.082 (0.063–0.100) <0.001
Mortality at 1 year
Base model 0.767 (0.741–0.793) 4.30 0.829 Reference
Model with SSI 0.823 (0.799–0.846) 8.88 0.353 0.101 (0.082–0.121) <0.001
Model with NIHSS 0.816 (0.793–0.840) 6.42 0.600 0.088 (0.070–0.106) <0.001
AUC area under the receiver operating characteristic curve, CI confidence interval, IDI integrated discrimination improvement, NIHSS National Institutes of Health
Stroke Scale, SSI stroke severity index
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